Act A - The Market Structure
Health Canada's Natural Health Product Regulations require that a natural health product seeking a market authorization demonstrate quantitative identity — that the product contains what it claims to contain, in the amount it claims to contain. For a botanical extract with a complex polyphenol profile, this requires a validated analytical method using HPLC — and the validation must meet the requirements of the NHP Regulations' Evidence for Quality standard, which specifies precision, accuracy, specificity, linearity, and range parameters that a method validation for pharmaceutical purposes meets at a different standard. A food chemist with extensive HPLC experience in the pharmaceutical sector may not have validated a method under the NHP Quality standard — which is different from both the pharmaceutical ICH Q2(R1) standard and the food chemistry AOAC standard in specific ways that matter for whether Health Canada accepts the submission.
This is a thin market within a thin market. HPLC method development is a standard food chemistry competency. HPLC method validation for NHP market authorization specifically is a practice developed by a much smaller population of chemists who have worked in the NHP product development sector. 'HPLC' on a resume does not distinguish these populations. The method validation report a chemist has produced does distinguish them — immediately and unambiguously.
Act B - The Story
Priya is CTO of a company producing standardized botanical extracts for the functional food market. Her company's flagship product — a proprietary wild blueberry polyphenol extract — was ready for Health Canada NHP market authorization except for one submission component: a validated HPLC method for quantifying the anthocyanin profile in the extract at the NHP Quality standard. She had tried to hire a food chemist with this specific experience three times over eighteen months. Each recruitment cycle produced food chemists with HPLC experience who had never validated a method under NHP requirements. She had been clear in the job descriptions about the requirement. She had filtered for candidates who mentioned 'NHP' and 'HPLC' together. The candidates who arrived knew both words but had not worked at their intersection.
Priya uploaded the company's NHP market authorization application draft (with the method validation section blank and a description of what was needed), the Health Canada Evidence for Quality guidance document for botanical NHPs, and the internal technical brief describing the anthocyanin profile the extract was required to demonstrate. She also uploaded the method development work her previous contractor had completed — which got the method partially developed but not to the validation stage.
Luca had completed his MSc in food chemistry at McGill on polyphenol HPLC method development in berry extracts, then spent fourteen months as a research associate on a Health Canada-funded project developing NHP analytical method standards for botanical extracts. His uploaded profile included his MSc thesis, two conference posters from his graduate research, the NHP method validation section from a market authorization he had contributed to during his research associate position (cleared for disclosure by the PI), and a blog post he had written for a food chemistry newsletter about the differences between NHP and AOAC method validation standards. He was between positions. He had applied to Priya's job posting in the second recruitment cycle. His application had not passed the initial screening because his only employment credentials were graduate research appointments without commercial industry titles.
The platform matched Luca's document corpus to Priya's employer corpus with high specificity: his thesis work on blueberry anthocyanin HPLC method development matched the exact compound class and matrix that Priya's technical brief described; his NHP method validation section demonstrated the specific regulatory validation framework her submission required; his blog post showed he understood the NHP/AOAC standard distinction that was the precise knowledge gap she had been trying to fill. Priya received the match explanation and recognized immediately that the thesis work alone — which she could read in the uploaded abstract — was more specific to her need than any candidate she had interviewed. She contacted Luca within the hour.
Act C - Why This Market Stays Broken Without Infrastructure
Luca's MSc thesis, his NHP method validation work, and his conference posters contained more specific, evaluable evidence of his qualification for Priya's role than any resume content could have expressed. That evidence was publicly available — his thesis was in the McGill library; his conference posters were in the Canadian Society for Chemistry conference archive. No part of the standard hiring infrastructure had any mechanism to index these documents and find their match in Priya's technical brief.
Priya spent eighteen months and approximately $45,000 in recruitment costs failing to find a candidate whose qualification was fully documented in publicly available academic sources. The match was not hidden. The infrastructure to find it had not been built.
Characters are fictional. Health Canada NHP market authorization analytical method validation requirements and the distinction between NHP, pharmaceutical, and AOAC validation standards are factual. DeeperPoint is building the infrastructure this story describes.